|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Megwalu UC and Sikora AG: Survival
outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck
Surg. 140:855–860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Connor KL, Pattle S, Kerr GR and Junor E:
Treatment, comorbidity and survival in stage III laryngeal cancer.
Head Neck. 37:698–706. 2015. View Article : Google Scholar
|
|
4
|
Berindan-Neagoe I, Monroig PC, Pasculli B
and Calin GA: MicroRNAome genome: A treasure for cancer diagnosis
and therapy. CA Cancer J Clin. 64:311–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valeri N, Braconi C, Gasparini P, Murgia
C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat
F, et al: MicroRNA-135b promotes cancer progression by acting as a
downstream effector of oncogenic pathways in colon cancer. Cancer
Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drayton RM, Dudziec E, Peter S, Bertz S,
Hartmann A, Bryant HE and Catto JW: Reduced expression of miRNA-27a
modulates cisplatin resistance in bladder cancer by targeting the
cystine/glutamate exchanger SLC7A11. Clin Cancer Res. 20:1990–2000.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ouyang H, Gore J, Deitz S and Korc M:
microRNA-10b enhances pancreatic cancer cell invasion by
suppressing TIP30 expression and promoting EGF and TGF-β actions.
Oncogene. 33:4664–4674. 2014. View Article : Google Scholar :
|
|
9
|
Zhou J, Zhang M, Huang Y, Feng L, Chen H,
Hu Y, Chen H, Zhang K, Zheng L and Zheng S: MicroRNA-320b promotes
colorectal cancer proliferation and invasion by competing with its
homologous microRNA-320a. Cancer Lett. 356:669–675. 2015.
View Article : Google Scholar :
|
|
10
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yongchun Z, Linwei T, Xicai W, Lianhua Y,
Guangqiang Z, Ming Y, Guanjian L, Yujie L and Yunchao H:
MicroRNA-195 inhibits non-small cell lung cancer cell
proliferation, migration and invasion by targeting MYB. Cancer
Lett. 347:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun X, Liu B, Zhao XD, Wang LY and Ji WY:
MicroRNA-221 accelerates the proliferation of laryngeal cancer cell
line Hep-2 by suppressing Apaf-1. Oncol Rep. 33:1221–1226.
2015.PubMed/NCBI
|
|
13
|
Tian Y, Fu S, Qiu GB, Xu ZM, Liu N, Zhang
XW, Chen S, Wang Y, Sun KL and Fu WN: MicroRNA-27a promotes
proliferation and suppresses apoptosis by targeting PLK2 in
laryngeal carcinoma. BMC Cancer. 14:678–689. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tai J, Xiao X, Huang ZG, Yu ZK, Chen XH,
Zhou WG, Chen XJ, Rao YS, Fang JG and Ni X: MicroRNAs regulate
epithelial-mesenchymal transition of supraglottic laryngeal cancer.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 48:499–503. 2013.In
Chinese. PubMed/NCBI
|
|
15
|
Xu Y, Wang K, Gao W, Zhang C, Huang F, Wen
S and Wang B: MicroRNA-106b regulates the tumor suppressor RUNX3 in
laryngeal carcinoma cells. FEBS Lett. 587:3166–3174. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou M, Liu W, Ma S, Cao H, Peng X, Guo L,
Zhou X, Zheng L, Guo L, Wan M, et al: A novel onco-miR-365 induces
cutaneous squamous cell carcinoma. Carcinogenesis. 34:1653–1659.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li
XB, Zhang C and Yang X, Yang ZZ and Yang X: Akt-p53-miR-365-cyclin
D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN
deficiency. Nat Commun. 4:2544–2554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gastaldi C, Bertero T, Xu N,
Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N,
Meneguzzi G, Sonkoly E, et al: miR-193b/365a cluster controls
progression of epidermal squamous cell carcinoma. Carcinogenesis.
35:1110–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tarasov VA, Matishov DG, Shin EF, Boĭko
NV, Timoshkina NN, Makhotkin MA, Lomonosov AM and Kirpiĭ AA:
Inheritable changes in miRNAs expression in HeLa cells after X-ray
and mitomycin C treatment. Genetika. 50:909–917. 2014.In
Russian.
|
|
20
|
Hamada S, Masamune A, Miura S, Satoh K and
Shimosegawa T: miR-365 induces gemcitabine resistance in pancreatic
cancer cells by targeting the adaptor protein SHC1 and
pro-apoptotic regulator BAX. Cell Signal. 26:179–185. 2014.
View Article : Google Scholar
|
|
21
|
Kang SM, Lee HJ and Cho JY: MicroRNA-365
regulates NKX2-1, a key mediator of lung cancer. Cancer Lett.
335:487–494. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith MP, Sanchez-Laorden B, O'Brien K,
Brunton H, Ferguson J, Young H, Dhomen N, Flaherty KT, Frederick
DT, Cooper ZA, et al: The immune microenvironment confers
resistance to MAPK pathway inhibitors through macrophage-derived
TNFα. Cancer Discov. 4:1214–1229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mittal S, Sharma A, Balaji SA, Gowda MC,
Dighe RR, Kumar RV and Rangarajan A: Coordinate hyperactivation of
Notch1 and Ras/MAPK pathways correlates with poor patient survival:
Novel therapeutic strategy for aggressive breast cancers. Mol
Cancer Ther. 13:3198–3209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bjerke GA, Yang CS, Frierson HF, Paschal
BM and Wotton D: Activation of Akt signaling in prostate induces a
TGFβ-mediated restraint on cancer progression and metastasis.
Oncogene. 33:3660–3667. 2014. View Article : Google Scholar :
|
|
25
|
Freudlsperger C, Horn D, Weißfuß S,
Weichert W, Weber KJ, Saure D, Sharma S, Dyckhoff G, Grabe N,
Plinkert P, et al: Phosphorylation of AKT(Ser473) serves as an
independent prognostic marker for radiosensitivity in advanced head
and neck squamous cell carcinoma. Int J Cancer. 136:2775–2785.
2015. View Article : Google Scholar
|
|
26
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McKay MM and Morrison DK: Integrating
signals from RTKs to ERK/MAPK. Oncogene. 26:3113–3121. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du J, Liu S, He J, Liu X, Qu Y, Yan W, Fan
J, Li R, Xi H, Fu W, et al: MicroRNA-451 regulates stemness of side
population cells via PI3K/Akt/mTOR signaling pathway in multiple
myeloma. Oncotarget. 6:14993–15007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ihle MA, Trautmann M, Kuenstlinger H, Huss
S, Heydt C, Fassunke J, Wardelmann E, Bauer S, Schildhaus HU,
Buettner R, et al: miRNA-221 and miRNA-222 induce apoptosis via the
KIT/AKT signalling pathway in gastrointestinal stromal tumours. Mol
Oncol. 9:1421–1433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang W, Ren F, Wu Q, Jiang D, Li H and Shi
H: MicroRNA-497 suppresses angiogenesis by targeting vascular
endothelial growth factor A through the PI3K/AKT and MAPK/ERK
pathways in ovarian cancer. Oncol Rep. 32:2127–2133.
2014.PubMed/NCBI
|
|
31
|
Xue G, Restuccia DF, Lan Q, Hynx D,
Dirnhofer S, Hess D, Rüegg C and Hemmings BA: Akt/PKB-mediated
phosphorylation of Twist1 promotes tumor metastasis via mediating
cross-talk between PI3K/Akt and TGF-β signaling axes. Cancer
Discov. 2:248–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stephens L, Anderson K, Stokoe D,
Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB,
McCormick F, Tempst P, et al: Protein kinase B kinases that mediate
phosphatidylinositol 3,4,5-trisphosphate-dependent activation of
protein kinase B. Science. 279:710–714. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Freudlsperger C, Burnett JR, Friedman JA,
Kannabiran VR, Chen Z and Van Waes C: EGFR-PI3K-AKT-mTOR signaling
in head and neck squamous cell carcinomas: Attractive targets for
molecular-oriented therapy. Expert Opin Ther Targets. 15:63–74.
2011. View Article : Google Scholar
|
|
34
|
Tsurutani J, Fukuoka J, Tsurutani H, Shih
JH, Hewitt SM, Travis WD, Jen J and Dennis PA: Evaluation of two
phosphorylation sites improves the prognostic significance of Akt
activation in non-small-cell lung cancer tumors. J Clin Oncol.
24:306–314. 2006. View Article : Google Scholar
|
|
35
|
Lin A, Piao HL, Zhuang L, Sarbassov D, Ma
L and Gan B: FoxO transcription factors promote AKT Ser473
phosphorylation and renal tumor growth in response to pharmacologic
inhibition of the PI3K-AKT pathway. Cancer Res. 74:1682–1693. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beck JT, Ismail A and Tolomeo C: Targeting
the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) pathway: An emerging treatment strategy for
squamous cell lung carcinoma. Cancer Treat Rev. 40:980–989. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gallay N, Dos Santos C, Cuzin L, Bousquet
M, Simmonet Gouy V, Chaussade C, Attal M, Payrastre B, Demur C and
Récher C: The level of AKT phosphorylation on threonine 308 but not
on serine 473 is associated with high-risk cytogenetics and
predicts poor overall survival in acute myeloid leukaemia.
Leukemia. 23:1029–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang J, Sun Q, Zhang Z, Ge S, Han ZG and
Chen WT: Loss of microRNA-143/145 disturbs cellular growth and
apoptosis of human epithelial cancers by impairing the MDM2-p53
feedback loop. Oncogene. 32:61–69. 2013. View Article : Google Scholar
|
|
39
|
Yang YK, Xi WY, Xi RX, Li JY, Li Q and Gao
YE: Micro-RNA-494 promotes cervical cancer proliferation through
the regulation of PTEN. Oncol Rep. 33:2393–2401. 2015.PubMed/NCBI
|
|
40
|
Zhao L, Liu W, Xiao J and Cao B: The role
of exosomes and 'exosomal shuttle microRNA' in tumorigenesis and
drug resistance. Cancer Lett. 356:339–346. 2015. View Article : Google Scholar
|
|
41
|
Won YS, Jeong JS, Kim SJ, Ju MH and Lee
SW: Targeted anti-cancer effect through microRNA-181a regulated
tumor-specific hTERT replacement. Cancer Lett. 356:918–928. 2015.
View Article : Google Scholar
|
|
42
|
Serpico D, Molino L and Di Cosimo S:
microRNAs in breast cancer development and treatment. Cancer Treat
Rev. 40:595–604. 2014. View Article : Google Scholar
|
